Literature DB >> 8359950

Completeness of cancer registration in Limburg, The Netherlands.

L J Schouten1, P Höppener, P A van den Brandt, J A Knottnerus, J J Jager.   

Abstract

The completeness of cancer registration in the IKL (Integraal Kankercentrum Limburg) cancer registry, Limburg, the Netherlands, was evaluated for the years 1988-1990 by means of the independent case ascertainment method. This study was performed in co-operation with the Registration Network of Family Practices (RNFP) of the University of Limburg. The RNFP is a centralized database used by general practitioners (GP), containing their patients' background variables and diagnoses. The contents of the two databases were compared using computerized record linkage. If the information from both databases differed, this was verified using the source forms of the cancer registry and the GP involved. By combining the information from both registries in this way it was determined which malignancies should have been registered by the cancer registry. The IKL cancer registry had recorded 307 of the 319 eligible malignancies (96.2%). Five of the 12 missed registrations could be attributed to systematic shortcomings in the notification procedures. The estimated completeness for all malignancies of the IKL cancer registry is comparable with the results from cancer registries outside the Netherlands which have been established for longer.

Entities:  

Mesh:

Year:  1993        PMID: 8359950     DOI: 10.1093/ije/22.3.369

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  64 in total

1.  Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry.

Authors:  A G Dinmohamed; Y van Norden; O Visser; E F M Posthuma; P C Huijgens; P Sonneveld; A A van de Loosdrecht; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-09-15       Impact factor: 11.528

2.  Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015.

Authors:  M van der Meulen; A G Dinmohamed; O Visser; J K Doorduijn; J E C Bromberg
Journal:  Leukemia       Date:  2017-04-28       Impact factor: 11.528

3.  Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Authors:  A G Dinmohamed; O Visser; Y van Norden; N M A Blijlevens; J J Cornelissen; G A Huls; P C Huijgens; P Sonneveld; A A van de Loosdrecht; G J Ossenkoppele; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-17       Impact factor: 11.528

4.  Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013.

Authors:  A G Dinmohamed; M Brink; O Visser; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2016-04-08       Impact factor: 11.528

5.  Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival.

Authors:  Joris W Derksen; Otto Visser; Guy Brutel de la Rivière; Eric J Meuleman; Eddi A Heldeweg; Brunolf W Lagerveld
Journal:  World J Urol       Date:  2012-05-22       Impact factor: 4.226

6.  Large variation between hospitals in follow-up for colorectal cancer in southern Netherlands.

Authors:  L N van Steenbergen; I H J T de Hingh; H J T Rutten; M C M Rijk; R G Orsini; J W W Coebergh; V E P P Lemmens
Journal:  Int J Colorectal Dis       Date:  2013-04-28       Impact factor: 2.571

7.  Which comorbid conditions predict complications after surgery for colorectal cancer?

Authors:  Valery E P P Lemmens; Maryska L G Janssen-Heijnen; Saskia Houterman; Kees D G W Verheij; Hendrik Martijn; Lonneke van de Poll-Franse; Jan Willem W Coebergh
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

8.  Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

Authors:  A G Dinmohamed; A Szabó; M van der Mark; O Visser; P Sonneveld; J J Cornelissen; M Jongen-Lavrencic; A W Rijneveld
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

9.  Was there shortening of the interval between diagnosis and treatment of colorectal cancer in southern Netherlands between 2005 and 2008?

Authors:  L N van Steenbergen; V E P P Lemmens; H J T Rutten; H Martijn; J W W Coebergh
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

10.  Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.

Authors:  Caroline D M Witjes; Henrike E Karim-Kos; Otto Visser; Esther de Vries; Jan N M IJzermans; Robert A de Man; Jan Willem W Coebergh; Cornelis Verhoef
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.